Volume 30, Issue 1 (June 2023)
J Birjand Univ Med Sci. 2023, 30(1): 79-86 |
Back to browse issues page
Research code: 456308
Ethics code: IR.BUMS.REC.1399.503
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini Rad M S, Najmodini M, Ghasemian Moghaddam M R. A comparative study of Fistulotomy and Sclerosing Agents in the management of perianal fistula: A randomized controlled clinical. Journals of Birjand University of Medical Sciences 2023; 30 (1) :79-86
URL: http://journal.bums.ac.ir/article-1-3265-en.html
URL: http://journal.bums.ac.ir/article-1-3265-en.html
1- Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
2- Department of Surgery, School of Medicine, Emam Reza Hospital, Birjand University of Medical Sciences, Birjand, Iran
3- Department of Surgery, School of Medicine, Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran ,dr.ghasemian54@gmail.com
2- Department of Surgery, School of Medicine, Emam Reza Hospital, Birjand University of Medical Sciences, Birjand, Iran
3- Department of Surgery, School of Medicine, Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran ,
Abstract: (541 Views)
Background and Aims: The perianal fistula is a pathological tract between two epithelial surfaces of the anorectal canal and perianal skin. The most common treatment method is fistulotomy which leads to complications, such as incontinency. The present is study aimeds to compare the results of fistulotomy surgery and sclerotherapy in the management of managing the perianal fistula.
Materials and Methods: This Randomized controlled clinical study was performed on 24 patients with anorectal fistula. The procedure performed for group 1 was surgical fistulotomy, and group 2 underwent sclerosant agent injection. Recovery time, recurrence rate, post-operative pain, and degree of incontinency were evaluated. The statistical analysis was performed in SPSS software (Version 18), and a p-value less than 0.05 was considered statistically significant.
Results: There were 5 (41.7%) men and 7 (58.3%) women in the sclerosing group, as well as 7 (58.3%) men and 5 (41.7%) women in the fistulotomy group. There was no significant relationship between the two groups (P=0.68). The recurrence rate was 3 cases (42.9%) in sclerosing group and 4 cases (57.1%) in the fistulotomy group, which was not statistically significant (P=0.65). The fecal continency score after sclerotherapy was greater than that in the fistulotomy group (P<0.05), and the length of hospitalization, post-surgery discomfort, and the time it took for the fistula to heal were all considerably shorter in the sclerosing group.
Conclusion: We concluded that injectable sclerotherapy is effective, safe, simple, acceptable and affordable in the treatment of perianal fistula.
*Corresponding Author: Mohammad Reza Ghasemian Moghaddam; Emails: dr.ghasemian54@gmail.com
Materials and Methods: This Randomized controlled clinical study was performed on 24 patients with anorectal fistula. The procedure performed for group 1 was surgical fistulotomy, and group 2 underwent sclerosant agent injection. Recovery time, recurrence rate, post-operative pain, and degree of incontinency were evaluated. The statistical analysis was performed in SPSS software (Version 18), and a p-value less than 0.05 was considered statistically significant.
Results: There were 5 (41.7%) men and 7 (58.3%) women in the sclerosing group, as well as 7 (58.3%) men and 5 (41.7%) women in the fistulotomy group. There was no significant relationship between the two groups (P=0.68). The recurrence rate was 3 cases (42.9%) in sclerosing group and 4 cases (57.1%) in the fistulotomy group, which was not statistically significant (P=0.65). The fecal continency score after sclerotherapy was greater than that in the fistulotomy group (P<0.05), and the length of hospitalization, post-surgery discomfort, and the time it took for the fistula to heal were all considerably shorter in the sclerosing group.
Conclusion: We concluded that injectable sclerotherapy is effective, safe, simple, acceptable and affordable in the treatment of perianal fistula.
*Corresponding Author: Mohammad Reza Ghasemian Moghaddam; Emails: dr.ghasemian54@gmail.com
You can also search for this author in: PubMed ResearchGate Scopus Google Scholar Google Scholar Profile
Type of Study: Original Article |
Subject:
General Surgery
Received: 2023/04/24 | Accepted: 2023/06/20 | ePublished: 2023/06/5
Received: 2023/04/24 | Accepted: 2023/06/20 | ePublished: 2023/06/5
References
1. Shawki S, Wexner SD. Idiopathic fistula-in-ano. World J Gastroenterol. 2011; 17(28): 3277-85. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160530/ [DOI:10.3748/wjg.v17.i28.3277] [PMID] []
2. Vogel JD, Johnson EK, Morris AM, Paquette IM, Saclarides TJ, Feingold DL, et al. Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum. 2016; 59(12): 1117-33. [DOI:10.1097/DCR.0000000000000733] [PMID]
3. Parks A, Gordon PH, Hardcastle J. A classification of fistula‐in‐ano. Br J Surg. 1976; 63(1): 1-12. https://bjssjournals.onlinelibrary.wiley.com/doi/abs/10.1002/bjs.1800630102 [DOI:10.1002/bjs.1800630102] [PMID]
4. Shanwani A, Nor AM, Amri N. Ligation of the intersphincteric fistula tract (LIFT): a sphincter-saving technique for fistula-in-ano. Dis Colon Rectum. 2010; 53(1): 39-42. [DOI:10.1007/DCR.0b013e3181c160c4] [PMID]
5. Lindsey I, Smilgin-Humphreys MM, Cunningham C, Mortensen NJ, George BD. A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum. 2002; 45(12): 1608-15. [DOI:10.1007/s10350-004-7247-0] [PMID]
6. Williams J, MacLeod C, Rothenberger D, Goldberg S. Seton treatment of high anal fistulae. Br J Surg. 1991; 78(10): 1159-61. [DOI:10.1002/bjs.1800781004] [PMID]
7. Van Koperen PJ, Wind J, Bemelman WA, Bakx R, Reitsma JB, Slors JFM. Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis Colon Rectum. 2008; 51: 1475-81. [DOI:10.1007/s10350-008-9354-9] [PMID]
8. Göttgens K, Janssen P, Heemskerk J, Van Dielen F, Konsten J, Lettinga T, et al. Long-term outcome of low perianal fistulas treated by fistulotomy: a multicenter study. Int J Colorectal Dis. 2015; 30(2): 209-13. [DOI:10.1007/s00384-014-2072-y] [PMID]
9. Baky Fahmy M, Ezzelarab S. Outcome of submucosal injection of different sclerosing materials for rectal prolapse in children. Pediatr Surg In. 2004; 20(5): 353-56. [DOI:10.1007/s00383-004-1197-4] [PMID]
10. Akram Y, Tarar K, Chaudry Z, Ilyas M, Ayyaz M, Cheema MA. Role of Sclerosing Agents in the Management of Early Haemorrhoids. Ann King Edw Med Univ. 2007; 13(4): 242. DOI: 10.21649/akemu.v13i4.120
11. Dessily M, Charara F, Chelala E, Donfut A-L, Alle J-L. Injection of a sclerosing agent as first line treatment in anal fissure. Acta Chir Belg. 2014; 114(4): 261-65. [DOI:10.1080/00015458.2014.11681023] [PMID]
12. Kazemeini A, Keramati M R, Fazeli M S, Keshvari A, Nasiri A, Zebardast J.. Factors affecting recurrence and long-term complications of Ligation of Intersphincteric Fistula Tract (LIFT) surgery in patients with anal fistula. Razi J Med Sci. 2019; 26(1): 89-98. URL: http://rjms.iums.ac.ir/article-1-5513-en.html
13. Liu Z, Song X, Ye F. Comparative study of postoperative complications after rubber band ligation (RBL) and RBL combined with sclerotherapy in treatment of second-and third-degree internal hemorrhoids. Indian Journal of Surgery. 2020; 82(3): 345-49. Corpus ID: 199668285 [DOI:10.1007/s12262-019-01959-4]
14. Jorge JMN, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993; 36(1): 77-97. [DOI:10.1007/BF02050307] [PMID]
15. Demirel AH, Seyfettin K. Silver nitrate cauterization for anal fistulas with high blind tract chemical therapy in complicated anal fistulas. Euroasian J Hepato-Gastroenterol. 2013; 3:49-53. https://www.ejohg.com/doi/EJOHG/pdf/10.5005/jp-journals-10018-1063 [DOI:10.5005/jp-journals-10018-1063]
16. Lobascio P, Laforgia R, Novelli E, Perrone F, Di Salvo M, Pezzolla A, et al. Short-term results of sclerotherapy with 3% polidocanol foam for symptomatic second-and third-degree hemorrhoidal disease. J Invest Surg. 2021; 34(10): 1059-65. [DOI:10.1080/08941939.2020.1745964] [PMID]
17. Tomiki Y, Ono S, Aoki J, Takahashi R, Ishiyama S, Sugimoto K, et al. Treatment of internal hemorrhoids by endoscopic sclerotherapy with aluminumpotassium sulfate and tannic acid. Diagn Ther Endosc. 2015; 2015. [DOI:10.1155/2015/517690] [PMID] []
18. Buchmann P, Allan RN, Thompson H, Alexander-Williams J. Carcinoma in a rectovaginal fistula in a patient with Crohn's disease. Am J Surg. 1980; 140(3): 462-63. [DOI:10.1016/0002-9610(80)90190-7] [PMID]
19. Zhou W, Shi Y, Zhang M, Li L. The Remission Effects of First Injection of Sclerotherapy for Pediatric Rectal Prolapse: A Systematic Review and Meta-Analysis. Front Surg. 2022; 9: 835235. [DOI:10.3389/fsurg.2022.835235] [PMID] []
20. Antao B, Bradley V, Roberts JP, Shawis R. Management of rectal prolapse in children. Dis Colon Rectum. 2005 Aug; 48(8): 1620-5. [DOI:10.1007/s10350-005-0074-0] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC